0.79
+0.0619(+8.47%)
Currency In USD
| Previous Close | NaN |
| Open | NaN |
| Day High | NaN |
| Day Low | NaN |
| 52-Week High | NaN |
| 52-Week Low | NaN |
| Volume | NaN |
| Average Volume | NaN |
| Market Cap | NaN |
| PE | NaN |
| EPS | NaN |
| Moving Average 50 Days | NaN |
| Moving Average 200 Days | NaN |
| Change | NaN |
If you invested $1000 in NeuroOne Medical Technologies Corporation (NMTC) since IPO date, it would be worth $65.74 as of September 08, 2025 at a share price of $0.793. Whereas If you bought $1000 worth of NeuroOne Medical Technologies Corporation (NMTC) shares 5 years ago, it would be worth $181 as of September 08, 2025 at a share price of $0.793.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
GlobeNewswire Inc.
Aug 18, 2025 12:30 PM GMT
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOn
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
GlobeNewswire Inc.
Jul 31, 2025 4:12 PM GMT
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferi
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
GlobeNewswire Inc.
Jul 31, 2025 12:30 PM GMT
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferi